"Researchers Find Chemotherapy after Bladder Cancer Surgery Improved Survival"
Patients that received chemotherapy after bladder cancer surgery demonstrated an approximately 30% lower risk of death than those that underwent surgery alone, according to an analysis to be presented by researchers at the Icahn School of Medicine at Mount Sinai at the 2015 Genitourinary Cancers Symposium. Lead researcher Matthew Galsky, MD and colleagues used a large database of patients diagnosed with cancer in the United States. Specifically, the study found that patients receiving adjuvant chemotherapy after surgical treatment had improved overall survival when compared to patients that received surgical treatment alone with only post-surgical observation. "Until now, data supporting adjuvant chemotherapy has been mixed," said lead Dr. Galsky, Associate Professor of Medicine, Hematology and Medical Oncology, and Assistant Professor, Urology at the Icahn School of Medicine at Mount Sinai. Learn more.
Mount Sinai Researchers Publish Critical Examination of New Brain Tumor Drug
Sep 23, 2024 View All Press ReleasesNew AI Tool by Mount Sinai Researchers Could Reshape Prostate Cancer Care
Sep 23, 2024 View All Press ReleasesNew Insights Into Intellectual Disability Genetics Emerge at Mount Sinai
Sep 23, 2024 View All Press ReleasesMount Sinai Expands Psychedelic Research Center With New Facility in Upper Manhattan
Sep 19, 2024 View All Press ReleasesNew Mount Sinai Study Reveals Disparities in Lung Cancer Testing
Sep 18, 2024 View All Press Releases